FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076256952> ?p ?o ?g. }

• W2076256952 endingPage "1518" @default.
• W2076256952 startingPage "1517" @default.
• W2076256952 abstract "The deposition of extracellular matrix (ECM) proteins, such as collagen and elastin, is one of the hallmarks of liver fibrosis. In recent years it has become increasingly clear that tissue repair and remodeling are highly dynamic processes, resulting in continuous synthesis and turnover of ECM components during hepatofibrogenesis, and in disease state-specific changes in both the quantitative amount and qualitative composition of the ECM.1 In the June 2012 issue of HEPATOLOGY, Pellicoro et al.2 elegantly demonstrate that elastin accumulation represents a distinct feature of advanced-stage liver fibrosis, because of both increased synthesis and decreased macrophage metalloelastase (MMP12)-mediated degradation. Taking these findings, and the results recently reported by Polasek et al.3 on a collagen-specific magnetic resonance (MR) contrast agent into account, we reasoned that elastin might be a promising novel target for molecular MR monitoring of ECM-remodeling during hepatic fibrosis. We therefore evaluated the accumulation of the gadolinium-containing elastin-specific MR contrast agent ESMA, which has been shown to facilitate noninvasive assessment of atherosclerotic plaque burden4 in experimental murine liver fibrosis using a clinical 3.0T Philips Achieva MRI scanner. Two hours after intravenous administration of 0.2 mmol/kg ESMA into healthy and carbon tetrachloride (CCl4)-treated c57bl/6 mice (0.6 mL CCl4/kg body weight; thrice weekly for 4 weeks; n = 3 mice per group), a three-dimensional high-resolution inversion recovery gradient echo delayed-enhancement MRI (DE-MRI; see Makowski et al.4 for details on MR parameters and methodology) of liver tissue indicated clear differences between normal and diseased animals (Fig. 1): while healthy livers displayed no focal contrast enhancement upon ESMA administration (Fig. 1D,E), very distinct perivascular signals were observed in large and medium-sized vessels in fibrotic livers (Fig. 1A,B). This observation was in line with periportal ECM deposition visualized using Elastica-Van-Gieson staining (Fig. 1C,F). Although these findings require further investigation (with regard to fibrosis stage, ESMA dose, timing, specificity, and quantification), they demonstrate that elastin-based molecular MRI, like collagen-based molecular MRI,3 may be suitable for noninvasive monitoring of ECM remodeling during liver fibrosis. As the collagen-to-elastin-ratio changes during the progression and regression of liver fibrosis,2 the selective or combined use of different molecular MR probes might be a promising strategy for translating the differential regulation of ECM proteins during fibrosis pro- and regression into novel noninvasive imaging techniques for the clinic. Elastin-based molecular MRI of liver fibrosis. C57bl/6 mice were treated with CCl4 thrice weekly (0.6 mL/kg, intraperitoneally) for 4 weeks to induce liver fibrosis (A-C) or treated with the vehicle (corn oil) as controls (D-F) and subjected to MRI using a clinical 3 T MR scanner (Achieva 3.0T, Philips Healthcare, Best, Netherlands). Two hours after the intravenous injection of an elastin-specific gadolinium-containing MR contrast agent (ESMA, BMS753951), significant perivascular T1 contrast enhancement (see arrows) was observed in fibrotic (A,B), but not in healthy control livers (D,E). Periportal elastin accumulation in fibrotic (C) versus healthy livers (F) was confirmed by way of Elastica-Van-Gieson staining, clearly demarcating the presence of collagen and elastin fibers in light red and dark purple, respectively. Results are representative of n = 3 animals per group. For details on MR scanning methodology and ESMA specificity, see Makowski et al.4 Supported by the German Research Foundation (DFG SFB/TRR57; TA434/2-1; EH412/1-1; LA2937/1-1) and British Heart Foundation (RG/12/1/29262). ESMA was kindly provided by David Onthank (Lantheus Medical Imaging, North Billerica, MA). JOSEF EHLING, M.D.1 MATTHIAS BARTNECK, PH.D.2 VIKTOR FECH2 BRITTA BUTZBACH, M.D.3 RICHARD CESATI, PH.D.4 RENE BOTNAR, PH.D.3 TWAN LAMMERS, PH.D., D.SC.1 FRANK TACKE, M.D., PH.D.2 1Department of Experimental Molecular Imaging University Hospital RWTH Aachen Aachen, Germany 2Department of Medicine III University Hospital RWTH Aachen Aachen, Germany 3Division of Imaging Sciences and Biomedical Engineering King's College London London, UK 4Lantheus Medical Imaging North Billerica, MA, USA" @default.
• W2076256952 created "2016-06-24" @default.
• W2076256952 creator A5043363489 @default.
• W2076256952 creator A5048357006 @default.
• W2076256952 creator A5050046573 @default.
• W2076256952 creator A5061307323 @default.
• W2076256952 creator A5075245764 @default.
• W2076256952 creator A5079522186 @default.
• W2076256952 creator A5083825910 @default.
• W2076256952 creator A5085384080 @default.
• W2076256952 date "2013-10-01" @default.
• W2076256952 modified "2023-10-16" @default.
• W2076256952 title "Elastin-based molecular MRI of liver fibrosis" @default.
• W2076256952 cites W2113608951 @default.
• W2076256952 cites W2120335459 @default.
• W2076256952 cites W2146967775 @default.
• W2076256952 cites W2167342453 @default.
• W2076256952 doi "https://doi.org/10.1002/hep.26326" @default.
• W2076256952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23424008" @default.
• W2076256952 hasPublicationYear "2013" @default.
• W2076256952 type Work @default.
• W2076256952 sameAs 2076256952 @default.
• W2076256952 citedByCount "36" @default.
• W2076256952 countsByYear W20762569522014 @default.
• W2076256952 countsByYear W20762569522015 @default.
• W2076256952 countsByYear W20762569522016 @default.
• W2076256952 countsByYear W20762569522017 @default.
• W2076256952 countsByYear W20762569522018 @default.
• W2076256952 countsByYear W20762569522019 @default.
• W2076256952 countsByYear W20762569522020 @default.
• W2076256952 countsByYear W20762569522021 @default.
• W2076256952 countsByYear W20762569522022 @default.
• W2076256952 countsByYear W20762569522023 @default.
• W2076256952 crossrefType "journal-article" @default.
• W2076256952 hasAuthorship W2076256952A5043363489 @default.
• W2076256952 hasAuthorship W2076256952A5048357006 @default.
• W2076256952 hasAuthorship W2076256952A5050046573 @default.
• W2076256952 hasAuthorship W2076256952A5061307323 @default.
• W2076256952 hasAuthorship W2076256952A5075245764 @default.
• W2076256952 hasAuthorship W2076256952A5079522186 @default.
• W2076256952 hasAuthorship W2076256952A5083825910 @default.
• W2076256952 hasAuthorship W2076256952A5085384080 @default.
• W2076256952 hasBestOaLocation W20762569522 @default.
• W2076256952 hasConcept C102124568 @default.
• W2076256952 hasConcept C126838900 @default.
• W2076256952 hasConcept C142724271 @default.
• W2076256952 hasConcept C143409427 @default.
• W2076256952 hasConcept C178790620 @default.
• W2076256952 hasConcept C185592680 @default.
• W2076256952 hasConcept C189165786 @default.
• W2076256952 hasConcept C2777359374 @default.
• W2076256952 hasConcept C2779869378 @default.
• W2076256952 hasConcept C2780559512 @default.
• W2076256952 hasConcept C2993667909 @default.
• W2076256952 hasConcept C55493867 @default.
• W2076256952 hasConcept C71924100 @default.
• W2076256952 hasConceptScore W2076256952C102124568 @default.
• W2076256952 hasConceptScore W2076256952C126838900 @default.
• W2076256952 hasConceptScore W2076256952C142724271 @default.
• W2076256952 hasConceptScore W2076256952C143409427 @default.
• W2076256952 hasConceptScore W2076256952C178790620 @default.
• W2076256952 hasConceptScore W2076256952C185592680 @default.
• W2076256952 hasConceptScore W2076256952C189165786 @default.
• W2076256952 hasConceptScore W2076256952C2777359374 @default.
• W2076256952 hasConceptScore W2076256952C2779869378 @default.
• W2076256952 hasConceptScore W2076256952C2780559512 @default.
• W2076256952 hasConceptScore W2076256952C2993667909 @default.
• W2076256952 hasConceptScore W2076256952C55493867 @default.
• W2076256952 hasConceptScore W2076256952C71924100 @default.
• W2076256952 hasIssue "4" @default.
• W2076256952 hasLocation W20762569521 @default.
• W2076256952 hasLocation W20762569522 @default.
• W2076256952 hasLocation W20762569523 @default.
• W2076256952 hasOpenAccess W2076256952 @default.
• W2076256952 hasPrimaryLocation W20762569521 @default.
• W2076256952 hasRelatedWork W1988454503 @default.
• W2076256952 hasRelatedWork W2288620160 @default.
• W2076256952 hasRelatedWork W2347377923 @default.
• W2076256952 hasRelatedWork W2355939533 @default.
• W2076256952 hasRelatedWork W2359831249 @default.
• W2076256952 hasRelatedWork W2382895565 @default.
• W2076256952 hasRelatedWork W2413403348 @default.
• W2076256952 hasRelatedWork W2419131078 @default.
• W2076256952 hasRelatedWork W2917795919 @default.
• W2076256952 hasRelatedWork W4387646365 @default.
• W2076256952 hasVolume "58" @default.
• W2076256952 isParatext "false" @default.
• W2076256952 isRetracted "false" @default.
• W2076256952 magId "2076256952" @default.
• W2076256952 workType "article" @default.